Hatzinger Martin
Erwachsenenpsychiatrie, Psychiatrische Dienste der Solothurner Spitäler AG.
Ther Umsch. 2010 Nov;67(11):585-91. doi: 10.1024/0040-5930/a000100.
Biological treatment procedures are based on evidence-based guidelines. According to all of them, a correct diagnosis of depression is required before starting therapy. Within recent years many different types of antidepressants have been introduced to the pharmacotherapeutic armamentarium. The "newer" antidepressants were developed with a view to reduced side effects. However, the classes of antidepressants currently available differ little in their antidepressant efficacy, thus, all producing treatment responses of 50 - 75 %. Therefore, the selection of a particular antidepressant for the individual patient depends on various factors: patient's prior experience with medication, concurrent medical conditions that may be worsened by selected antidepressants, concomitant use of non-psychiatric medications that may lead to negative drug-drug interactions, a drug's short and long-term side effects, physician's experience with the medication and patient's history of adherence to medication. Importantly, if the patient does not show any improvement after two to four weeks of treatment with an antidepressant dose at the upper level of the standard dose, it becomes less likely that he will respond to this particular medication later. When a partial or non-response is present, several therapeutic options are available: (1) combining two antidepressants from different classes, (2) switch to new antidepressant from a different or the same pharmacological class and (3) augmentation strategies. For patients who are reluctant to take traditional antidepressants, herbal remedies such as hypericum perforatum (St. John's Wort) provide an alternative for treatment of mild to moderate depression. Besides pharmacological treatment options non pharmacological biological interventions are available. Electroconvulsive therapy and partial sleep deprivation are very effective in the treatment of acute depression. Especially for seasonal affective disorders light therapy is a well established treatment alternative. Further new biological treatment approaches such as rapid transcranial magnetic stimulation (rTMS) showed inconsistent results.
生物治疗程序基于循证指南。根据所有这些指南,在开始治疗前需要对抑郁症进行正确诊断。近年来,许多不同类型的抗抑郁药已被引入药物治疗手段中。“新型”抗抑郁药的研发旨在减少副作用。然而,目前可用的抗抑郁药类别在抗抑郁疗效方面差异不大,因此,所有药物产生的治疗反应率均为50% - 75%。因此,为个体患者选择特定的抗抑郁药取决于多种因素:患者先前的用药经验、所选抗抑郁药可能会加重的并发疾病、可能导致不良药物相互作用的非精神科药物的联合使用、药物的短期和长期副作用、医生对该药物的经验以及患者的用药依从史。重要的是,如果患者在使用标准剂量上限的抗抑郁药治疗两到四周后没有任何改善,那么他随后对这种特定药物产生反应的可能性就会降低。当出现部分反应或无反应时,有几种治疗选择:(1)联合使用不同类别的两种抗抑郁药,(2)换用不同或相同药理类别的新型抗抑郁药,以及(3)增效策略。对于不愿服用传统抗抑郁药的患者,草药如贯叶连翘(圣约翰草)为治疗轻度至中度抑郁症提供了一种替代选择。除了药物治疗选择外,还有非药物生物干预措施。电休克疗法和部分睡眠剥夺在治疗急性抑郁症方面非常有效。特别是对于季节性情感障碍,光疗是一种成熟的治疗选择。进一步的新生物治疗方法,如快速重复经颅磁刺激(rTMS),结果并不一致。